Abstract

Hyperglycemic hyperosmolar nonketoacidotic coma developed in a twenty-year-old female with uremia when treated for hypertension with intravenous diazoxide. Low circulating serum insulin concentrations were found in this patient as well as in four others with this syndrome, thus supporting the recent hypothesis that these concentrations of insulin are adequate to block lipolysis but insufficient to prevent hyperglycemia. In view of the recognized inhibitory effect of diazoxide on pancreatic insulin release and peripheral glucose nietabolism, it is recommended that patients receiving intravenous diazoxide be observed for possible severe disturbances of carbohydrate metabolism and resulting hyperosmolarity.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.